
Vibha Jawa, PhD, chief scientific officer at EpiVax, explains why the need for animal studies varies by modality and what it takes for organ-on-chip and other human-relevant models to replace these studies in IND-enabling toxicology work.
AbbVie’s Contract Manufacturing Business has been serving our partners globally for more than 35 years. Our contract development and manufacturing capabilities span, Drug Product, Potent, Hot Melt Extrusion, Fermentation, Prefilled Syringes, Biologics, Packaging and Bulk Active Pharmaceutical Ingredients (APIs) across 9 production facilities in North America and Europe. You can contact us at
Company name: AbbVie
Website:
E-mail: abbviecontractmfg@abbvie.com






